BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8902183)

  • 1. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 2. Pruritus induced by interruption of paroxetine therapy.
    Mazzatenta C; Peonia G; Martini P
    Br J Dermatol; 2004 Apr; 150(4):787. PubMed ID: 15099390
    [No Abstract]   [Full Text] [Related]  

  • 3. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome.
    Murata Y; Kobayashi D; Imuta N; Haraguchi K; Ieiri I; Nishimura R; Koyama S; Mine K
    J Clin Psychopharmacol; 2010 Feb; 30(1):11-7. PubMed ID: 20075642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy.
    Diler RS; Tamam L; Avci A
    J Clin Psychopharmacol; 2000 Oct; 20(5):586-7. PubMed ID: 11001250
    [No Abstract]   [Full Text] [Related]  

  • 6. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK; McKenzie J; Worrall N
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract]   [Full Text] [Related]  

  • 7. Should paroxetine be used to treat depression during pregnancy?
    Mintzes B; Jureidini J
    Am J Psychiatry; 2008 Nov; 165(11):1487; author reply 1487-8. PubMed ID: 18981077
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxetine: a review of clinical experience.
    Dunner D; Kumar R
    Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
    Vergouwen AC; Bakker A
    Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akathisia: a review and case report following paroxetine treatment.
    Baldassano CF; Truman CJ; Nierenberg A; Ghaemi SN; Sachs GS
    Compr Psychiatry; 1996; 37(2):122-4. PubMed ID: 8654061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paxil and self-scratching.
    Weintrob A
    J Am Acad Child Adolesc Psychiatry; 2001 Jan; 40(1):5. PubMed ID: 11195562
    [No Abstract]   [Full Text] [Related]  

  • 13. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
    Yasui-Furukori N; Kaneko S
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis after paroxetine treatment.
    Ahmed R; Eagleton C
    N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline discontinuation syndrome presenting with severe depression and compulsions.
    Benazzi F
    Biol Psychiatry; 1998 Jun; 43(12):929-30. PubMed ID: 9627752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paroxetine in the treatment of depressive disorders (pilot study)].
    Svestka J; Novotný V; Kamenická V; Obrovská V; Cesková E
    Cesk Psychiatr; 1995 Jul; 91(3):135-42. PubMed ID: 7553946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More cases of paroxetine withdrawal syndrome.
    Pacheco L; Malo P; Aragues E; Etxebeste M
    Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
    [No Abstract]   [Full Text] [Related]  

  • 19. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events.
    Ramasubbu R
    Can J Psychiatry; 2003 May; 48(4):281-2. PubMed ID: 12776398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.